Skip to the page

Data / Form D filings / Avertix Medical, Inc.

Avertix Medical, Inc.: Form D filings

Avertix Medical, Inc., a health care company in Eatontown, NJ, filed 15 Form D notices with the SEC between 2012 and 2025. The latest, on September 23, 2025, reports $1 million sold of a $5 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
40 CHRISTOPHER WAY, SUITE 201, Eatontown, NJ, 07724
Phone
(732) 542-5551
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1564031

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 23, 2025New notice$5,000,000$1,011,667$3,988,3334Sep 10, 2025sec.gov
Mar 11, 2025Amendment$22,650,000$14,253,772$8,396,22840Sep 5, 2024sec.gov
Sep 9, 2024New notice$14,650,000$6,757,873$7,892,1278Sep 5, 2024sec.gov
Aug 14, 2024New notice$28,411,917$7,092,079$21,319,83859Jul 31, 2024sec.gov
May 10, 2024Amendment$15,000,000$13,480,307$1,519,69353Oct 31, 2023sec.gov
Nov 13, 2023New notice$9,400,000$6,788,763$2,611,23739Oct 31, 2023sec.gov
Mar 1, 2023New notice$38,007,957$34,252,457$3,755,50082Feb 15, 2023sec.gov
Sep 6, 2022New notice$6,500,000$6,000,000$500,00020Aug 22, 2022sec.gov
Aug 17, 2021New notice$7,500,000$3,857,162$3,642,83839Jul 30, 2021sec.gov
Apr 1, 2019New notice$15,000,000$10,000,000$5,000,00056Mar 29, 2019sec.gov
Jan 17, 2019New notice$2,500,000$600,000$1,900,0002Jan 7, 2019sec.gov
Dec 8, 2014New notice$20,500,000$10,215,000$10,285,00022Nov 25, 2014sec.gov
Dec 16, 2013Amendment$20,546,000$20,531,000$15,00023Dec 5, 2012sec.gov
Apr 3, 2013Amendment$17,535,000$17,535,00019Dec 5, 2012sec.gov
Dec 13, 2012New notice$17,525,000$3,762,500$13,762,50017Dec 5, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Christopher PucilloDirector
Sean L. CullinanDirector
Richard L. SchatzDirector
David L. KeenanExecutive Officer
Joseph P. BerardoDirector
Timothy P. MoranExecutive Officer, Director
Tom MendellDirector
Phillip L. TomExecutive Officer

Other health care companies in New Jersey that filed recently

Every Form D from the week of Sep 22, 2025 · All recent filings in New Jersey · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Avertix Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.